Stocks TelegraphStocks Telegraph
Stock Ideas

DWTX Company Profile and Key Details

NASDAQ : DWTX

Dogwood Therapeutics, Inc.

$3.15
1.28+68.45%
At Close 4:00 PM
$2.97
-0.18-5.71%
After-Market 07:59 PM

DWTX Stock Price Chart

Stock Price Today

Dogwood Therapeutics, Inc. (DWTX) stock surged +68.45%, trading at $3.15 on NASDAQ, up from the previous close of $1.87. The stock opened at $2.53, fluctuating between $2.05 and $3.99 in the recent session.

Stock Snapshot

1.87
Prev. Close
2.53
Open
4.2M
Market Cap
1.33M
Number of Shares
2.0505
Day Low
3.99
Day High
-0.5
P/E Ratio
93.75%
Free Float in %
-6.32
EPS (TTM)
N/A
Book Value
N/A
Cash Flow per Share
24.15M
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Jan 21, 20252.533.992.053.1524.15M
Jan 17, 20251.991.991.871.8717.39K
Jan 16, 20252.212.241.921.9348.32K
Jan 15, 20252.232.282.172.208.95K
Jan 14, 20252.312.342.102.2345.4K
Jan 13, 20252.342.442.292.329.69K
Jan 10, 20252.382.442.362.366.8K
Jan 08, 20252.562.682.382.3830.6K
Jan 07, 20252.862.862.492.6551.64K
Jan 06, 20252.782.932.522.5716.53K
Jan 03, 20252.632.752.482.6110.9K
Jan 02, 20252.602.602.422.5122.31K
Dec 31, 20242.822.862.482.4917.06K
Dec 30, 20242.832.962.702.8525.53K
Dec 27, 20242.772.942.612.8233.9K
Dec 26, 20242.973.002.622.6221.33K
Dec 24, 20242.602.882.502.8734.9K
Dec 23, 20242.832.982.332.7284K
Dec 20, 20242.302.632.302.3433.4K
Dec 19, 20242.422.442.322.3210.49K

Contact Details

Alpharetta, GA 30009

United States

Website: https://www.dwtx.comContact: 866 620 8655

About Company

Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, Inc. and changed its name to Dogwood Therapeutics, Inc. in October 2024. The company was founded in 2012 and is headquartered in Alpharetta, Georgia.

Company Information

Employees4
Beta1.57
Sales or RevenueN/A
5Y Sales Change%N/A
Fiscal Year EndsN/A
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Dogwood Therapeutics, Inc. (DWTX) stock price?

Dogwood Therapeutics, Inc. (NASDAQ: DWTX) stock price is $3.15 in the last trading session. During the trading session, DWTX stock reached the peak price of $3.99 while $2.05 was the lowest point it dropped to. The percentage change in DWTX stock occurred in the recent session was 68.45% while the dollar amount for the price change in DWTX stock was $1.28.

DWTX's industry and sector of operation?

The NASDAQ listed DWTX is part of Biotechnology industry that operates in the broader Healthcare sector. Dogwood Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of DWTX?

No Data

How DWTX did perform over past 52-week?

DWTX's closing price is 94.44% higher than its 52-week low of $1.62 where as its distance from 52-week high of $15.73 is -79.97%.

How many employees does DWTX have?

Number of DWTX employees currently stands at 4.

Link for DWTX official website?

Official Website of DWTX is: https://www.dwtx.com

How do I contact DWTX?

DWTX could be contacted at phone 866 620 8655 and can also be accessed through its website. DWTX operates from 44 Milton Avenue, Alpharetta, GA 30009, United States.

How many shares of DWTX are traded daily?

DWTX stock volume for the day was 24.15M shares. The average number of DWTX shares traded daily for last 3 months was 47.57K.

What is the market cap of DWTX currently?

The market value of DWTX currently stands at $4.20M with its latest stock price at $3.15 and 1.33M of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph